A proposed role for the immune system in the pathogenesis of hepatitis B virus induced liver disease.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Critical reviews in clinical laboratory sciences

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10408368109105874PMID 6459211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.

  1981cited by this paper
• Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.

  1981cited by this paper
• Liver-specific protein in perspective

  1980cited by this paper
• Lymphocyte cooperation is required for amplification of macrophage procoagulant activity

  1980cited by this paper
• Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2".

  1979cited by this paper
• Role of macrophages in natural resistance to virus infections

  1979cited by this paper
• Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).

  1979cited by this paper
• Chronic active hepatitis: immunopathogenesis and immunotherapy.

  1979cited by this paper
• Familial abnormalities of suppressor-cell function in systemic lupus erythematosus.

  1979cited by this paper
• Extrahepatic manifestations of hepatitis B virus infection.

  1979cited by this paper
• Alteration in suppressor cell activity in chronic active hepatitis.

  1978cited by this paper
• Serum factor inhibition of lymphocyte proliferation and suppressor T cell function in alcoholic and chronic active liver diseases

  1978cited by this paper
• Lymphocyte cytotoxicity against Chang liver cells in chronic active hepatitis.

  1978cited by this paper
• Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

  1978cited by this paper
• T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.

  1978cited by this paper
• Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.

  1978cited by this paper
• Cell-mediated cytotoxicity in chronic active liver disease: a new test system.

  1978cited by this paper
• Regulation of human lymphocyte function by a soluble extract from normal human liver.

  1978cited by this paper
• Cell-mediated cytotoxicity in chronic active liver disease: A new test system

  1978cited by this paper
• Lymphocytotoxicity test against rabbit hepatocytes in chronic liver diseases.

  1978cited by this paper
• Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes.

  1977cited by this paper
• Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG

  1977cited by this paper
• HLA and chronic active hepatitis (CAH).

  1977cited by this paper
• HLA and chronic active hepatitis.

  1977cited by this paper
• H–2 gene expression is required for T cell-mediated lysis of virus-infected target cells

  1977cited by this paper
• Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.

  1977cited by this paper
• Identification of lymphocytes in percutaneous liver biopsy cores. Different T:B cell ratio in HB sAg-positive and -negative hepatitis.

  1977cited by this paper
• In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

  1977cited by this paper
• Immunoregulatory properties of human plasma in very low density lipoproteins.

  1977cited by this paper
• T and B lymphocytes in patients with chronic active hepatitis (CAH).

  1977cited by this paper
• Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses.

  1977cited by this paper
• Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis.

  1977cited by this paper
• Purification and characterization of human liver-specific membrane lipoprotein (LSP).

  1977cited by this paper
• Augmentation of Proliferation of Human Mixed Lymphocyte Culture by Human α-Fetoprotein

  1977cited by this paper
• THE BIOREGULATORY PROPERTIES OF SERUM LOW DENSITY LIPOPROTEIN INHIBITOR (LDL-IN) ON THE GENERATION OF KILLER T CELLS

  1977cited by this paper
• T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection

  1977cited by this paper
• SERUM FACTORS WHICH SUPPRESS THE IMMUNE RESPONSE

  1977cited by this paper
• Augmentation of proliferation of human mixed lymphocyte culture by human alpha-fetoprotein.

  1977cited by this paper
• Host specificity of a serum marker for hepatitis B: evidence that "e antigen" has the properties of an immunoglobulin.

  1977cited by this paper
• Recovery of soluble sheep erythrocyte receptor from the T lymphocyte surface by proteolytic cleavage.

  1977cited by this paper
• Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes.

  1976cited by this paper
• Establishment of a continuously growing cell line from primary carcinoma of the liver.

  1976cited by this paper
• Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

  1976cited by this paper
• Cell-mediated immunity in lumphocytic choriomeningitis. I. The specificity of the cytotoxic T lymphocytes.

  1976cited by this paper
• Immunosuppression by micromolecular fibrinogen degradation products in cancer

  1976cited by this paper
• The role of immunological mechanisms in chronic hepatitis.

  1976cited by this paper
• The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

  1976cited by this paper
• Studies on the Pathogenesis of Experimental Chronic Active Hepatitis in Rabbits

  1976cited by this paper
• Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

  1976cited by this paper
• Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

  1976cited by this paper
• Viral hepatitis: clinical aspects.

  1975cited by this paper
• Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions

  1975cited by this paper
• Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.

  1975cited by this paper
• Immune response to hepatitis B surface antigen

  1975cited by this paper
• Immunopathological aspects of hepatitis type B.

  1975cited by this paper
• Cell-mediated immunity in acute and chronic hepatitis.

  1975cited by this paper
• RELATIONSHIP OF THE BIOSYNTHESIS OF α‐FETOPROTEIN, ALBUMIN, HEMOPEXIN, AND HAPTOGLOBIN TO THE GROWTH STATE OF FETAL RAT HEPATOCYTE CULTURES *

  1975cited by this paper
• Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients.

  1975cited by this paper
• Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein

  1975cited by this paper
• Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: Studies in hepatic and non-hepatic diseases

  1975cited by this paper
• Extrahepatic manifestations of viral hepatitis.

  1975cited by this paper
• Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

  1975cited by this paper
• Immunological aspects of hepatitis B virus infection.

  1975cited by this paper
• Lymphocyte stimulation in hepatitis B infections.

  1975cited by this paper
• Relationship of the biosynthesis of alpha-fetoprotein, albumin, hemopexin, and haptoglobin to the growth state of fetal rat hepatocyte cultures.

  1975cited by this paper
• HL-A 1,8 PHENOTYPE AND HBS ANTIGENÆMIA IN HÆMODIALYSIS PATIENTS

  1975cited by this paper
• Pathogenesis of experimental viral hepatitis (second of two parts).

  1974cited by this paper
• Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system

  1974cited by this paper
• T cell control of antibody production.

  1974cited by this paper
• Maintenance of latent herpetic infection: an apparent role for anti-viral IgG.

  1974cited by this paper
• T and B lymphocytes in acute and chronic hepatitis.

  1974cited by this paper
• Antibody-induced redistribution of measles virus antigens on the cell surface.

  1974cited by this paper
• Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

  1974cited by this paper
• Role of the thymus in tolerance. X. "Suppressor" activity of antigen-stimulated rat thymocytes transferred to normal recipients.

  1973cited by this paper
• Liver specific antigens. Purification and characterization.

  1972cited by this paper
• Cell-mediated Immunity in Patients Positive for Hepatitis-associated Antigen

  1972cited by this paper
• Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

  1972cited by this paper
• Cellular immunity and hepatitis-associated, Australia antigen liver disease.

  1972cited by this paper
• New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

  1972cited by this paper
• Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

  1972cited by this paper
• Lymphocyte transformation and alcoholic liver injury.

  1972cited by this paper
• New Specificities in Australia Antigen Positive Sera Distinct from the Le Bouvier Determinants

  1972cited by this paper
• The heterogeneity of Australia antigen.

  1971cited by this paper
• Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

  1971cited by this paper
• The heterogeneity of Australia antigen.

  1971cited by this paper
• Lymphocyte Transformation and Hepatitis I. Impairment of Thymidine Incorporation and DNA Polymerase Activity 1

  1971cited by this paper
• Viral hepatitis. New light on an old disease.

  1970cited by this paper
• Transmission of serum hepatitis.

  1970cited by this paper
• Australia antigen as a hepatitis virus. Variation in host response.

  1970cited by this paper
• Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

  1970cited by this paper
• IN VITRO INTERACTION OF MOUSE HEPATITIS VIRUS AND MACROPHAGES FROM GENETICALLY RESISTANT MICE

  1970cited by this paper
• A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

  1969cited by this paper
• SPINA BIFIDA CYSTICA.

  1964cited by this paper
• Francis Adams (1796-1861)

  1961cited by this paper
• MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY.

  1960cited by this paper
• Fatal complications of virus hepatitis in two patients with agammaglobulinemia.

  1960cited by this paper
• Continuous Subcultivation of Epithelial-like Cells from Normal Human Tissues.∗

  1954cited by this paper
• Continuous subcultivation of epithelial-like cells from normal human tissues.

  1954cited by this paper
• The differential diagnosis of 207 hospitalized cases of peptic ulcer.

  1946cited by this paper

• Pathogen Discovery

  2008cites this paper
• Risk factors for development of lethal sequelae after hepatitis B virus infection in humans.

  1984cites this paper